Two of the area’s largest medical systems are working on vaccine research targeting the more transmissible South African variant of the coronavirus.
The University of Rochester Medical Center and Rochester Regional Health have joined national studies to test a vaccine for the variant.
URMC and RRH have joined two phase 3 clinical trials to test the new vaccine as a booster and as a stand-alone vaccine.